NETWORK ANALYSIS FOR IDENTIFICATION OF DIAGNOSTIC BIOMARKERS OF GLIOMA USING NGS DATA

Read full text Summarise with VIRAT
Authors: Aqsa Naz, Naima Iqbal, Alisha Aftab, Falak Naz, Nafeesa Tahir, Saadia Momal Zafar, Rafia Anwer
Cited by: 0
References: 23

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background Gliomas are the most common primary brain tumors worldwide, about 80% of all primary brain tumors. Approximately 200,000 cases are diagnosed annually worldwide. Low-grade gliomas (LLGs) are less aggressive and have better survival outcomes, though they have a wide survival range from 1 to 15 years, depending on their subtype. There is great need to identify diagnostic biomarkers for glioma. Objective To investigate brain tumor glioma, through network analyzing of deferentially expressed genes(DEGs) between normal and tumor tissues by exploring the molecular pathways dysregulated in the disease context, and integrating these findings to understand the tumor's molecular landscape holistically. This approach aims to uncover diagnostic biomarkers for early detection and therapeutic targets to improve treatment outcomes for patients with this aggressive cancer. Methods In this study, two datasets obtained from the Chinese Glioma Genome Atlas (CGGA) were evaluated glioma for Glioma associated DEGs using bioinformatics analysis. On the basis of p-value

Fields of Study & Subjects

Glioma Diagnosis and Treatment Bioinformatics and Genomic Networks Cancer-related molecular mechanisms research

Publication details

Journal / source
Insights-Journal of Health and Rehabilitation
Volume
4
Issue
3
Pages
1–9
Publication date
22 March 2026
Language
EN